Xiaoxi Lv
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cell Biology top 5%
- Endoplasmic Reticulum Stress and Disease
Papers in
- Epidemiology 17
- Autophagy in Disease and Therapy 14
- Co-authors
- Fang Hua (27 shared papers)Zhuowei Hu (26 shared papers)Bing Cui (24 shared papers)Jiaojiao Yu (20 shared papers)Xiaowei Zhang (23 shared papers)Shanshan Liu (14 shared papers)Ke Li (13 shared papers)Jinmei Yu (13 shared papers)
- Journals
- Acta Pharmaceutica Sinica B (9 papers)Advances in experimental medicine and biology (4 papers)Nature Communications (3 papers)Science Translational Medicine (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xiaoxi Lv
42 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 106
- Cancer Research 296
- Cell Biology 283
- Immunology 276
- Molecular Biology 897
- Hepatology 97
Countries citing papers authored by Xiaoxi Lv
This map shows the geographic impact of Xiaoxi Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxi Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxi Lv more than expected).
Fields of papers citing papers by Xiaoxi Lv
This network shows the impact of papers produced by Xiaoxi Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxi Lv. The network helps show where Xiaoxi Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoxi Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 162 | |
| 2 | 2012 | 141 | |
| 3 | 2018 | 134 | |
| 4 | 2019 | 132 | |
| 5 | 2022 | 100 | |
| 6 | 2017 | 94 | |
| 7 | 2021 | 90 | |
| 8 | 2020 | 86 | |
| 9 | 2013 | 49 | |
| 10 | 2013 | 49 | |
| 11 | 2018 | 47 | |
| 12 | 2013 | 45 | |
| 13 | 2019 | 43 | |
| 14 | 2016 | 42 | |
| 15 | 2019 | 41 | |
| 16 | 2020 | 40 | |
| 17 | 2021 | 32 | |
| 18 | 2020 | 30 | |
| 19 | 2021 | 27 | |
| 20 | 2017 | 26 |
About Xiaoxi Lv
Xiaoxi Lv is a scholar working on Epidemiology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Surgery, having authored 43 papers that have together received 1.7k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (14 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Endoplasmic Reticulum Stress and Disease (6 papers), Immune Cell Function and Interaction (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immune Response and Inflammation (3 papers), Neonatal Respiratory Health Research (3 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (296 citations), Cell Biology (283 citations), Immunology (276 citations), Molecular Biology (897 citations) and Hepatology (97 citations). Xiaoxi Lv has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Fang Hua, Zhuowei Hu, Bing Cui, Jiaojiao Yu, Xiaowei Zhang, Shanshan Liu, Ke Li, Jinmei Yu, Shuang Shang and Bo Huang. Their work appears in journals such as Acta Pharmaceutica Sinica B, Advances in experimental medicine and biology, Nature Communications, Science Translational Medicine and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.